Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilman B Drueke

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Kidney International|January 29, 2021
Cardiovascular and renal risk reduction in type 2 diabetes---which choice?Tilman B Drueke
Kidney International|October 18, 2020
Increase in phosphaturia by inhibition of renal sodium-dependent phosphate cotransporter NPT2aTilman B Drueke
Jornal Brasileiro De Nefrologia|May 28, 2020
Bone biopsy in chronic kidney disease: still an option?Tilman B Drueke
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 18, 2020
The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney diseaseAnatole Besarab, Tilman B Drueke
Kidney International|May 22, 2024
Characterizing the cellular and molecular landscape of mineralocorticoid action and antagonism in the kidneyVerónica Miguel, Tilman B Drueke
Kidney International|April 17, 2016
Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?Christina M Wyatt, Tilman B Drueke
European Journal of Preventive Cardiology|March 4, 2025
Cardiovascular disease in patients with chronic kidney disease - arteriosclerosis vs. atherosclerosisZiad A Massy, Tilman B Drueke
Kidney International|July 7, 2025
Role of ceramides in the pathogenesis of atherosclerosisTilman B Drueke, Ziad A Massy
Kidney International|February 11, 2023
Vascular calcification is accelerated by interleukin-29Tilman B Drueke, Ziad A Massy
Kidney International|February 15, 2022
Role of uremic toxins in vascular disease-the end of nihilism?Ziad A Massy, Tilman B Drueke
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Kidney International|January 29, 2021
Cardiovascular and renal risk reduction in type 2 diabetes---which choice?Tilman B Drueke
Kidney International|October 18, 2020
Increase in phosphaturia by inhibition of renal sodium-dependent phosphate cotransporter NPT2aTilman B Drueke
Jornal Brasileiro De Nefrologia|May 28, 2020
Bone biopsy in chronic kidney disease: still an option?Tilman B Drueke
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 18, 2020
The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney diseaseAnatole Besarab, Tilman B Drueke
Kidney International|May 22, 2024
Characterizing the cellular and molecular landscape of mineralocorticoid action and antagonism in the kidneyVerónica Miguel, Tilman B Drueke
Kidney International|April 17, 2016
Higher hemoglobin levels and quality of life in patients with advanced chronic kidney disease: no longer a moving target?Christina M Wyatt, Tilman B Drueke
European Journal of Preventive Cardiology|March 4, 2025
Cardiovascular disease in patients with chronic kidney disease - arteriosclerosis vs. atherosclerosisZiad A Massy, Tilman B Drueke
Kidney International|July 7, 2025
Role of ceramides in the pathogenesis of atherosclerosisTilman B Drueke, Ziad A Massy
Kidney International|February 11, 2023
Vascular calcification is accelerated by interleukin-29Tilman B Drueke, Ziad A Massy
Kidney International|February 15, 2022
Role of uremic toxins in vascular disease-the end of nihilism?Ziad A Massy, Tilman B Drueke
Pageof 7